medigraphic.com
ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México

2010, Number 1

<< Back Next >>

Arch Inv Mat Inf 2010; 2 (1)

Experiencia de seis años en pacientes con nefropatía de Henoch-Schönlein

Rodríguez RJM, López CMB

Language: Spanish
References: 22
Page: 34-37
PDF size: 62.74 Kb.


ABSTRACT

Introduction: Henoch-Schönlein purpura (HSP) is the most common vasculitis in childhood. The renal disease is the most common complication and potentially severe, occurs in 25 to 40% of patients. Objective: To determine the experience in treating patients with Henoch-Schönlein nephropathy (NHS) in the Nephrology Department of the Hospital for Children of IMIEM. Methods: A retrospective, descriptive and observational study. We included all patients diagnosed with PHS, in search of kidney disease. Period 1 January 2003 to December 31, 2008. We used measures of central tendency. Results: There were 226 records of patients diagnosed with PHS, of these 54 had renal disease and secondary NHS confirmed in 16 patients. Of these 15 continue their control by the outpatient nephrology and one destination is unknown. Nine (56.2%) were male and 7 (43.8%) female. The signs were presented at the beginning were: petechiae (100%), edema (37.5%), abdominal pain (37.5%), arthritis (62.5%). Nephrological diagnoses were: nephrotic syndrome 13 (81.3%), nephritic syndrome 3 (18.8%), two (12.5%) patients developed renal failure. The oral steroid treatment was 16 (100%), steroid boluses 15 (93.8%), immunosuppressive 9 (56.3%). The results to treatment corticoid 9 (56.3%), remission of nephrotic syndrome 13 (81.3%), remission of nephritic syndrome 3 (18.8%), renal disease remission 4 (25%). So far 14 (87.5%) with preserved renal function. Conclusions: The diagnosis and treatment are very useful.


REFERENCES

  1. Coopo R. Henoch-Schönlein purpura: the most common vasculitis in children with severe renal involvement. Rev Port Nefrol Hipert 2004; 18: 197-213.

  2. Inoue CN, Chiba Y, Morimoto T, Nishio T, Kondo Y, Adachi M, Matsutani S. Tonsillectomy in the treatment of pediatric Henoch-Schönlein nephritis. Clin Nephrol 2007; 67: 298-305.

  3. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal and minimal urinary findings a systemic review. Arch Dis Child 205; 90: 916-920.

  4. Kaku Y, Nohara K, Honda S. Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors. Kidney Int 1998; 53: 1755-1759.

  5. National High Blood Pressure Education Program Working Group on high blood pressure in children and adolescents. The fourth report on the diagnosis, evaluation and treatment. Pediatrics 2004; 114: 555-576.

  6. Zamora I, Vallo A. Registro Español Pediátrico de insuficiencia renal terminal (REPIR), 1998. Nefrología 2000; 20: 32-39.

  7. Shenoy M, Bradbury MG, Lewis MA, Webb N. Outcome of Henoch-Schönlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol 2007; 22: 1717-1722.

  8. Schärer K, Armar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schönlein-Henoch purpura nephritis in children. Pediatr Nephrol 1999: 13: 816-823.

  9. Chang WL, Yang YH, Wang LC, Lin YT, Chiang BL. Renal manifestations in Henoch-Schönlein purpura: a 10-year clinical study. Pediatr Nephrol 2005; 20: 1259-1272.

  10. Vila-Cost J, Jiménez-Llort A, Camacho-Díaz JA, Vila-Santandreu A. Nefropatía en la púrpura de Henoch-Schönlein: estudio retrospectivo de los últimos 25 años. An Pediatr (Bar) 2007; 66: 290-293.

  11. Algoet C, Proesmans W. Renal biopsy 2-9 years after Henoch-Schönlein purpura. Pediatr Nephrol 2003; 18: 471-473.

  12. Huber AM, King J, McLaine M, Klassen F, Pothos M. A randomized placebo-controlled trial of prednisone in early Henoch-Schönlein purpura. BMC Medicine 2004; 2: 7.

  13. Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study. Lancet 2002; 360: 666-670.

  14. Coppo R, Mazzucco L, Lugo A, Schena FP. For the Italian group of renal immunopathology collaborative study on Henoch-Schönlein purpura. Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Nephrol Dial Transplant 1997; 12: 2277-2283.

  15. Ronkainen J, Ala-Houhala M, Autio-Harmainen H, Jahnukainen T, Koskimies O, Merenmies J et al. Long-term outcome 19 years after childhood IgA nephritis, a retrospective cohort study. Pediatr Nephrol 2006; 21: 1266-1273.

  16. Barrat I, Martin T, Avner ED, Harmon WE. Pediatric Nephrology. Editors. 4th ed. IgA Nephropathy and Henoch-Schönlein Nephritis VI; 691-706.

  17. Nefrología Pediátrica. Gustavo Gordillo Paniagua. 2ª ed. Nefropatía de la púrpura anafilactoide y mensagiopatía por depósito de IgA. 17: 225-232.

  18. Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L. Predictors of outcome in Henoch-Schönlein nephritis in children and adults. Am J Kidney Dis 2006; 47: 993-1003.

  19. Mir S, Yavascan O, Mutlubas F, Yeniay B, Sonmez F. Clinical outcome in children with Henoch-Schönlein nephritis. Pediatr Nephrol 2007; 22: 64-70.

  20. Kawasaki Y, Suzuki J, Sakai N, Remoto K, Nozawa R, Suzuki S, Suzuki H. Clinical and pathological features of children with Henoch-Schönlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol 2003; 60: 153-160.

  21. Rai A, Nast C, Adler S. Henoch-Schönlein purpura nephritis. J Am Soc Nephrol 1999; 10: 2637-2644.

  22. The Kidney. Editors Brenner and rector’s the kidney/edited by Barry M.- 6th Vol II: 1302-1310.




2020     |     www.medigraphic.com